234 related articles for article (PubMed ID: 11331437)
1. Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute Cooperative Research and Development Studies.
Murgo AJ
Oncologist; 2001; 6 Suppl 2():22-8. PubMed ID: 11331437
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies.
Douer D; Tallman MS
J Clin Oncol; 2005 Apr; 23(10):2396-410. PubMed ID: 15800332
[TBL] [Abstract][Full Text] [Related]
3. Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent.
Amadori S; Fenaux P; Ludwig H; O'dwyer M; Sanz M
Curr Med Res Opin; 2005 Mar; 21(3):403-11. PubMed ID: 15811209
[TBL] [Abstract][Full Text] [Related]
4. Advances in the management of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide.
Slack JL; Waxman S; Tricot G; Tallman MS; Bloomfield CD
Oncologist; 2002; 7 Suppl 1():1-13. PubMed ID: 11961204
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide in the treatment of haematological malignancies.
Kwong YL
Expert Opin Drug Saf; 2004 Nov; 3(6):589-97. PubMed ID: 15500417
[TBL] [Abstract][Full Text] [Related]
6. Expanding the use of arsenic trioxide: leukemias and beyond.
Chen Z; Chen GQ; Shen ZX; Sun GL; Tong JH; Wang ZY; Chen SJ
Semin Hematol; 2002 Apr; 39(2 Suppl 1):22-6. PubMed ID: 12012319
[TBL] [Abstract][Full Text] [Related]
7. Arsenic derivatives in hematologic malignancies: a role beyond acute promyelocytic leukemia?
Verstovsek S; Giles F; Quintás-Cardama A; Perez N; Ravandi-Kashani F; Beran M; Freireich E; Kantarjian H
Hematol Oncol; 2006 Dec; 24(4):181-8. PubMed ID: 16783836
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies.
Tallman MS
Blood Rev; 2001 Sep; 15(3):133-42. PubMed ID: 11735161
[No Abstract] [Full Text] [Related]
9. The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future.
Evens AM; Tallman MS; Gartenhaus RB
Leuk Res; 2004 Sep; 28(9):891-900. PubMed ID: 15234563
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide.
Litzow MR
Expert Opin Pharmacother; 2008 Jul; 9(10):1773-85. PubMed ID: 18570609
[TBL] [Abstract][Full Text] [Related]
11. Arsenicals in hematologic cancers.
Novick SC; Warrell RP
Semin Oncol; 2000 Oct; 27(5):495-501. PubMed ID: 11049017
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide and acute promyelocytic leukemia: clinical and biological.
Chen Z; Zhao WL; Shen ZX; Li JM; Chen SJ; Zhu J; Lallemand-Breittenbach V; Zhou J; Guillemin MC; Vitoux D; de Thé H
Curr Top Microbiol Immunol; 2007; 313():129-44. PubMed ID: 17217042
[TBL] [Abstract][Full Text] [Related]
13. Swallowing a bitter pill-oral arsenic trioxide for acute promyelocytic leukemia.
Torka P; Al Ustwani O; Wetzler M; Wang ES; Griffiths EA
Blood Rev; 2016 May; 30(3):201-11. PubMed ID: 26709030
[TBL] [Abstract][Full Text] [Related]
14. Introduction: the history of arsenic trioxide in cancer therapy.
Antman KH
Oncologist; 2001; 6 Suppl 2():1-2. PubMed ID: 11331433
[TBL] [Abstract][Full Text] [Related]
15. New data with arsenic trioxide in leukemias and myelodysplastic syndromes.
Sekeres MA
Clin Lymphoma Myeloma; 2007 Dec; 8 Suppl 1():S7-S12. PubMed ID: 18282365
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide in hematological malignancies: the new discovery of an ancient drug.
Bonati A; Rizzoli V; Lunghi P
Curr Pharm Biotechnol; 2006 Dec; 7(6):397-405. PubMed ID: 17168655
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with arsenic trioxide for hematological malignancies.
Takahashi S
Anticancer Agents Med Chem; 2010 Jul; 10(6):504-10. PubMed ID: 20812901
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience of arsenic trioxide in relapsed acute promyelocytic leukemia.
Soignet SL
Oncologist; 2001; 6 Suppl 2():11-6. PubMed ID: 11331435
[TBL] [Abstract][Full Text] [Related]
19. Application and assessment of Chinese arsenic drugs in treating malignant hematopathy in China.
Hu XM; Liu F; Ma R
Chin J Integr Med; 2010 Aug; 16(4):368-77. PubMed ID: 20697951
[TBL] [Abstract][Full Text] [Related]
20. [Progression of foundational and clinical studies on use of arsenic trioxide in treatment of lymphoma--review].
Li LH; Li HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1335-9. PubMed ID: 18088496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
